Atypical haemolytic uraemic syndrome: a case of rare genetic mutation.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
30 Jul 2021
Historique:
entrez: 31 7 2021
pubmed: 1 8 2021
medline: 4 8 2021
Statut: epublish

Résumé

Complement-mediated kidney disease has been an evolving area in the field of nephrology. Atypical haemolytic uraemic syndrome (aHUS) is a rare thrombotic microangiopathy that affects multiple organs, particularly kidneys. The disease is characterised by a triad of haemolytic anaemia, thrombocytopenia and acute kidney injury (AKI). aHUS is most commonly caused by dysregulation of alternative complement pathway. In contrast to shiga toxin-associated haemolytic uraemic syndrome, diarrheal prodrome is usually absent in children with aHUS. We report a 2-year, 9-month-old boy who presented with acute dysentery and AKI. He had an unusual prolonged course of illness with hypocomplementaemia; hence, genetic testing was performed. He had a storming course in the hospital and succumbed to complications of the disease. Genetic study revealed digenic mutation in

Identifiants

pubmed: 34330731
pii: 14/7/e244190
doi: 10.1136/bcr-2021-244190
pmc: PMC8327850
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Pediatr Nephrol. 2012 Dec;27(12):2327-31
pubmed: 22903728
Indian Pediatr. 2020 Aug 15;57(8):744-747
pubmed: 32844761
Kidney Int. 2018 Aug;94(2):408-418
pubmed: 29907460
Ther Apher Dial. 2019 Feb;23(1):4-21
pubmed: 30294946
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):217-225
pubmed: 27913483
Curr Opin Pediatr. 2013 Apr;25(2):209-15
pubmed: 23399570
Hematology Am Soc Hematol Educ Program. 2012;2012:617-25
pubmed: 23233643
J Atheroscler Thromb. 2019 Feb 1;26(2):99-110
pubmed: 30393246
Pediatr Nephrol. 2019 Aug;34(8):1465-1482
pubmed: 30989342
Korean J Intern Med. 2020 Jan;35(1):25-40
pubmed: 31935318
Pediatr Nephrol. 2016 Jan;31(1):15-39
pubmed: 25859752
Kidney Int. 2021 Jul;100(1):225-237
pubmed: 33307104
Kidney Int. 2016 Mar;89(3):701-11
pubmed: 26880462
Clin Adv Hematol Oncol. 2016 Nov;14 Suppl 11(11):2-15
pubmed: 27930620
Int J Nephrol. 2011;2011:908407
pubmed: 21876803
Clin Epidemiol. 2020 Mar 12;12:295-305
pubmed: 32210633
Clin J Am Soc Nephrol. 2007 May;2(3):591-6
pubmed: 17699467

Auteurs

Geminiganesan Sangeetha (G)

Department of Paediatric Nephrology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India sangeethaperungo@gmail.com.

Jaippreetha Jayaraj (J)

Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.

Swathi Ganesan (S)

Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.

Sreeapoorva Puttagunta (S)

Department of Paediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH